Comparison of Safety and Efficacy of Buflomedil and Naftidrofuryl in the Treatment of Intermittent Claudication
Published May 1, 1981 · Guillermo Rosas, Cristina Cerdeyra, Miguel A. Lucas
Angiology
Q2 SJR score
19
Citations
0
Influential Citations
Abstract
In a group of 58 patients with peripheral arteriopathies, we have studied efficacy and safety of buflomedil hydrochloride and naftidrofuryl. Both drugs have been shown to have vasoactive properties evaluated through walking capacity and time of hyperemia. According to our results, buflomedil is more effective and safe than naftidrofuryl in the treatment of patients with intermittent claudication.
Study Snapshot
Key takeawayBuflomedil is more effective and safer than naftidrofuryl in treating intermittent claudication in peripheral arteriopathies.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
···
···
···
···